Reuters logo
BRIEF-Glycomimetics reports qtrly net loss per share of $0.34
2017年5月8日 / 下午1点12分 / 5 个月前

BRIEF-Glycomimetics reports qtrly net loss per share of $0.34

May 8 (Reuters) - Glycomimetics Inc

* Glycomimetics reports program updates and first quarter 2017 results

* Qtrly net loss per share $0.34

* Qtrly loss per share $0.34

* Phase 3 program to evaluate Rivipansel for vaso-occlusive sickle cell crisis, according to Pfizer, remains on track for completion in H2 2018 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below